- /
- Supported exchanges
- / US
- / NPCE.NASDAQ
Neuropace Inc (NPCE NASDAQ) stock market data APIs
Neuropace Inc Financial Data Overview
NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. In addition, the company provides physician tablet which is used for prescribing and managing clinicians for programming implanted devices and managing patient care; and patient data management system, a secure online database that collects data that have been recorded by the RNS System; and nSight Platform, which provide clinicians with personalized patient reports, as well as programming suggestions. It sells its products to hospital facilities for initial RNS System implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Neuropace Inc (top by weight)
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Neuropace Inc data using free add-ons & libraries
Get Neuropace Inc Fundamental Data
Neuropace Inc Fundamental data includes:
- Net Revenue: 99 530 K
- EBITDA: -16 510 000
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-05-13
- EPS/Forecast: -0.2296
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Neuropace Inc News
New
NeuroPace (NPCE) Down 0.6% Since Last Earnings Report: Can It Rebound?
It has been about a month since the last earnings report for NeuroPace, Inc. (NPCE). Shares have lost about 0.6% in that time frame, outperforming the S&P 500. But investors have to be wondering, wil...
Here's Why You Should Add NeuroPace Stock to Your Portfolio Now
NeuroPace, Inc. NPCE is well-positioned for solid growth, driven by strong RNS adoption, expanding referral networks and AI-driven innovations that enhance efficiency and utilization. The potential IG...
NPCE Receives FDA Approval for AI-Powered ECoG Assistant for Epilepsy
NeuroPace NPCE recently announced that the FDA has approved its ECoG Assistant, its first AI-driven feature to assist clinicians in epilepsy care. With this approval, the company takes a step forward ...
Is NPCE Stock a Buy in 2026 After DIXI Exit and Margin Lift?
NeuroPace, Inc. NPCE is moving through a clean strategic reset in 2026. The company is exiting the DIXI Medical distribution business and leaning fully into its core responsive neurostimulation franch...
Corporate Events Calendar & News package for
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.